Kapil Maithal

Safety and Immunogenicity of a DNA SARS-CoV-2 vaccine (ZyCoV-D): Results of an open-label, non-randomized phase I part of phase I/II clinical study by intradermal route in healthy subjects in India

Taufik Momin, Kevinkumar Kansagra, Hardik B. Patel et al. · EClinicalMedicine · 2021 · 183 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models

Ayan Dey, T.M. Chozhavel Rajanathan, Harish Chandra et al. · Vaccine · 2021 · 136 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Synthetic peptides as inactivators of multimeric enzymes: inhibition of <i>Plasmodium falciparum</i> triosephosphate isomerase by interface peptides

Sreelekha K. Singh, Kapil Maithal, Hemalatha Balaram et al. · FEBS Letters · 2001 · 53 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Inhibition of Plasmodium falciparum Triose-phosphate Isomerase by Chemical Modification of an Interface Cysteine

Kapil Maithal, Gudihal Ravindra, Hemalatha Balaram et al. · Journal of Biological Chemistry · 2002 · 42 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Assessment of packed bed bioreactor systems in the production of viral vaccines

R. Rajendran, Rajendra Lingala, Siva Kumar Vuppu et al. · AMB Express · 2014 · 36 citations · Full text

Engineering, Bioengineering, Infectious Diseases +16